Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Thompson

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Orphanet Journal of Rare Diseases|June 22, 2023
The evolution of the mitochondrial disease diagnostic odysseyJohn L P Thompson, Amel Karaa, Hung Pham, et al.
JAMA|February 6, 2004
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic strokeSteven R Levine, Robin L Brey, Barbara C Tilley, et al.
Stroke|January 24, 2013
Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapyW T Longstreth, Richard A Kronmal, John L P Thompson, et al.
Stroke|February 27, 2010
Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trialE Clarke Haley, John L P Thompson, James C Grotta, et al.
European Journal of Clinical Investigation|February 26, 2019
Pulse pressure and prognosis in patients with heart failure with reduced ejection fractionNeeraj Shah, Min Qian, Marco R Di Tullio, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 28, 2013
Designing clinical trials for dystoniaWendy R Galpern, Christopher S Coffey, Alberto Albanese, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 11, 2014
Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trialPatrick M Pullicino, Min Qian, Ralph L Sacco, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 8, 2013
Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trialPatrick M Pullicino, John L P Thompson, Ralph L Sacco, et al.
International Journal of Cardiology|December 3, 2014
Association of quality of life with anticoagulant control in patients with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trialJonathan A Shaffer, John L P Thompson, Bin Cheng, et al.
JACC. Heart Failure|August 5, 2017
Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF TrialJohn R Teerlink, Min Qian, Natalie A Bello, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Orphanet Journal of Rare Diseases|June 22, 2023
The evolution of the mitochondrial disease diagnostic odysseyJohn L P Thompson, Amel Karaa, Hung Pham, et al.
JAMA|February 6, 2004
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic strokeSteven R Levine, Robin L Brey, Barbara C Tilley, et al.
Stroke|January 24, 2013
Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapyW T Longstreth, Richard A Kronmal, John L P Thompson, et al.
Stroke|February 27, 2010
Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trialE Clarke Haley, John L P Thompson, James C Grotta, et al.
European Journal of Clinical Investigation|February 26, 2019
Pulse pressure and prognosis in patients with heart failure with reduced ejection fractionNeeraj Shah, Min Qian, Marco R Di Tullio, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 28, 2013
Designing clinical trials for dystoniaWendy R Galpern, Christopher S Coffey, Alberto Albanese, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 11, 2014
Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trialPatrick M Pullicino, Min Qian, Ralph L Sacco, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 8, 2013
Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trialPatrick M Pullicino, John L P Thompson, Ralph L Sacco, et al.
International Journal of Cardiology|December 3, 2014
Association of quality of life with anticoagulant control in patients with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trialJonathan A Shaffer, John L P Thompson, Bin Cheng, et al.
JACC. Heart Failure|August 5, 2017
Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF TrialJohn R Teerlink, Min Qian, Natalie A Bello, et al.
Pageof 9